Astellas Pharma Inc. and XenoPort, Inc. (XNPT) Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome
11/19/2009 8:44:56 AM
More...
|
Astellas Pharma Inc. (JOBS) Buys Rights to New IBS Drug from Ironwood; Astellas Will Pay $75 Million Upfront
11/10/2009 6:30:51 AM
More...
|
Theravance, Inc. (THRX) and Astellas Pharma Inc. Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
11/6/2009 11:05:14 AM
More...
|
Astellas Pharma Inc. (JOBS) Cuts Outlook as Generic Competition Heats Up
11/5/2009 7:34:59 AM
More...
|
Cardiome Pharma Corp. (COM.TO) And Astellas Pharma Inc. Announce Initiation Of Patient Enrolment In ACT 5 Trial
10/29/2009 10:41:14 AM
More...
|
Astellas Pharma Inc. (JOBS), Medivation, Inc. (MDVN) (JOBS) in Prostate-Cancer Drug Pact; Astellas to Pay $110 Million Up Front; Medivation Eligible for $655 Million Milestone Payments
10/27/2009 6:35:05 AM
More...
|
Zogenix, Inc. and Astellas Pharma Inc. Announce Data Published Showing the Benefits of SUMAVEL(TM) DosePro(TM) Needle-Free Delivery System
10/22/2009 10:53:54 AM
More...
|
Japan's Astellas Pharma Inc. (JOBS) Settles with IMPAX Laboratories, Inc. (IPXL) on Prostate Drug
10/7/2009 4:45:32 AM
More...
|
Astellas Pharma Inc. (JOBS) Gets 6 Month Extra Flomax Patent Protection
9/25/2009 7:00:42 AM
More...
|
Astellas Pharma Inc. Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back
9/22/2009 10:50:19 AM
More...
|
|